Overview Flortaucipir 18F PET Imaging in BIOCARD Study Status: Terminated Trial end date: 2018-08-17 Target enrollment: Participant gender: Summary This study is designed to assess the imaging characteristics of Flortaucipir (18F-AV-1451) in subjects who participated in the Biomarkers of Cognitive Decline Among Normal Individuals (BIOCARD) study at Johns Hopkins University. Phase: Phase 1 Details Lead Sponsor: Avid Radiopharmaceuticals